Cancer Research | Penn Today

Cancer treatment has come far, fast: Better prevention, early detection, new treatment

Carl June of the Perelman School of Medicine was awarded a $3 million Breakthrough Prize in life sciences for developing CAR-T therapy to treat cancer.

Fluorescent microscopy of colon cancer cells..

Genetic switch turns tumor suppressor into oncogene in colorectal cancer

Researchers from the School of Veterinary Medicine have shown that an enzyme that suppresses early-stage colorectal cancer switches to become an oncogene as the cancer progresses.

Microscopic rendering of a white blood cell amongst red blood cells.

An immunotherapy strategy against all blood cancers

Researchers at Penn Medicine have demonstrated a new potential treatment using CAR T cell therapy using a CRISPR base-editing to develop a method called “epitope editing.”

Carl June with a microphone in the Penn Medicine atrium with the celebratory flash mob.

Carl June on the boundless potential of CAR T cell therapy

In a Q & A, June, the Richard W. Vague Professor in Immunotherapy, and Daniel Baker, a fourth-year doctoral student in Penn’s Cell and Molecular Biology department, discuss how the treatment can extend to treating diseases beyond cancer.

After years of research, Pitt professor poised to test breast cancer vaccine

A Penn study testing a breast cancer vaccine in those who carry the breast cancer gene has vaccinated its first patient.

Philly gene therapy companies tap into city’s workforce training program for lab techs

Penn Medicine is noted for spearheading gene therapy for cancer treatment, being the first in the nation to use a gene editing tool to combat cancer in 2019.

Microscopic view of a DNA chain disintegrating.

QR code for cancer cells

Researchers from Penn Engineering have created a new synthetic biology approach to uncover why some cells become resistant to anti-cancer therapies.

Blackstone president’s foundation awards $15 million to cancer researchers in Greater Boston

Jon and Mindy Gray are noted for their cancer-related donations to the Perelman School of Medicine’s Basser Center, which they established in 2012.

Cancer patients with bowel obstructions may benefit from surgery

Robert Krouse of the Perelman School of Medicine comments on research that suggests surgery should be offered sooner rather than later to patients with advanced abdominal tumors.

Antibody treatment prevents graft versus host disease in advanced preclinical tests

Penn Medicine, Dana-Farber Cancer Institute, and Boston Children’s Hospital research finds single antibody treatment blocked donor T-cell attack and increased survival rates in preclinical models.

Filters